Senores Pharmaceuticals Ltd
Registered Office:
#.1101-1103 11th Flr South Twr,Ambali Bopal Road,
Ahmedabad
-
380054,
Phone : +91-79-2999 9857
Fax : NA
Initial public offering of up to [*] equity shares of face value of (Rs) 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of (Rs) [*] per equity share (including a share premium of (Rs) [*] per equity share) ("Offer Price") aggregating up to (Rs) [*] crores (the "Offer"). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto (Rs) 500.00 crores (the "Fresh Issue") and an offer for sale of up to 2,100,000 equity shares (the "Offered Shares") aggregating up to (Rs) [*] crores (the "Offer for Sale"), comprising up to 250,000 equity shares aggregating to (Rs) [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to (Rs) [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to (Rs) [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to (Rs) [*] crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company.
The offer includes a reservation of up to 75,000 equity shares, aggregating up to (Rs) [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer".
Price Band: (Rs) 372 to (Rs) 391 per equity share of face value of (Rs) 10 each.
The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares.
Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.
Opens On
Closes On
Application
Allotment
20-Dec-24
24-Dec-24
372.00-391.00
0.00-0.00
Minimum Application for shares in Nos :
38
Further Multiples of :
38
(Rs.Cr)
Lead Managers to the Issue
Project Cost
0.00
Ambit Pvt Ltd
Project Financed through Current Offer
578.12
Post Issue Equity Share Capital
46.05
Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility
Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI
Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris
Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Swapnil Jatinbhai
Ashokkumar Vijaysingh Barot
Anar Swapnil Shah